Cite
No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]
MLA
Scott D. Newsome, et al. “No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].” Neurology and Therapy, vol. 12, no. 6, Oct. 2023, pp. 1909–35. EBSCOhost, https://doi.org/10.1007/s40120-023-00549-7.
APA
Scott D. Newsome, Cherie Binns, Ulrike W. Kaunzner, Seth Morgan, & June Halper. (2023). No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]. Neurology and Therapy, 12(6), 1909–1935. https://doi.org/10.1007/s40120-023-00549-7
Chicago
Scott D. Newsome, Cherie Binns, Ulrike W. Kaunzner, Seth Morgan, and June Halper. 2023. “No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].” Neurology and Therapy 12 (6): 1909–35. doi:10.1007/s40120-023-00549-7.